Feb. 03, 2011
Revision of Financial Forecasts for the Fiscal Year Ending March 31, 2011
Dainippon Sumitomo Pharma Co., Ltd. announces revisions of its financial forecasts for the year ending March 31, 2011, which reflects changes in the Company's business performances since the previous forecasts announced on October 29, 2010.
(Millions of yen)
1. Revision of Consolidated Financial Forecasts for the Year Ending March 31, 2011
|Net sales||Operating income||Ordinary income||Net income||Earnings per share|
|Previous Forecasts (A)||365,000||18,000||15,500||9,000||¥22.65|
|New forecasts (B)||365,000||22,000||19,500||11,000||¥27.69|
|(Reference) Results for the year ended March 31, 2010||296,261||35,624||33,837||20,958||¥52.75|
2. Reason for revision
Net sales are expected to proceed according to the previous financial forecasts.
However, on the cost side, selling, general and administrative expenses are expected to decrease from the previous forecasts, mainly due to a decrease in research and development costs.
Consequently, in the revised consolidated financial forecasts for the year ending March 31, 2011, the Company anticipates that net sales are in accordance with the previous forecasts, 365.0 billion yen, operating income increases 4.0 billion yen to 22.0 billion yen, ordinary income increases 4.0 billion yen to 19.5 billion yen and net income increases 2.0 billion yen to 11.0 billion yen compared to the previous forecasts dated October 29, 2010.
Note: Forecasts shown above are based on management's assumptions and beliefs in light of the information currently available, and involves risks and uncertainties. Actual financial results may differ materially depending on a number of factors, including economic conditions.